by Analia Katriniuk | Jul 16, 2025 | Blog, Uncategorized
Following the recent announcement of our expanded post-market surveillance services at LAMA, we’re now taking a closer look at one of the most critical components of that offering: pharmacovigilance. While post-market surveillance covers a wide range of activities,...
by Analia Katriniuk | Jul 14, 2025 | Blog
As you may know, LAMA has its roots in regulatory support for medical devices. That focus helped us build a strong network across Latin America and introduced us to some incredible professionals working in related areas. Over time, one thing became clear; we wanted to...
by Analia Katriniuk | Jul 11, 2025 | Blog
Expanding into Latin America is a major opportunity, but it’s also a serious undertaking. At LAMA, we’ve helped companies across industries enter the region with confidence, clarity, and long-term success. The truth is: LATAM rewards those who prepare, adapt, and...
by Analia Katriniuk | Mar 28, 2025 | Blog
What is Dengue? Dengue is a viral infection transmitted principally by the Aedes aegypti mosquito. It is prevalent in tropical and subtropical regions, especially during the rainy season when mosquito populations surge. The disease is caused by four distinct but...
by Analia Katriniuk | Feb 19, 2025 | Blog
Chile’s regulatory landscape for medical devices is evolving, and navigating it requires an understanding of the current rules as well as preparation for upcoming changes. This guide offers a comprehensive overview of the requirements for entering the Chilean market,...
by Analia Katriniuk | Feb 19, 2025 | Blog
At the AI Action Summit in Paris today, President of the European Commission Ursula von der Leyen made a groundbreaking announcement—an additional €50 billion investment will be made towards AI development, adding to a massive €150 billion already pledged by private...
